Cancer is one of the leading causes of death worldwide, affecting over 20 million individuals and killing 9.7 million in 2022 alone. Each of ~200 cancer types (and multiple subtypes) presents an ...

Reverse phase protein array (RPPA) is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body ...

Antibody-based reverse-phase protein arrays to quantitatively analyze specific protein pathways and their activation states with large sample sets (tissue or cells). Approximately 290+ validated ...

Led by Lisa Kubiak, RN, the Athens, Georgia clinic now provides Genesis Regenerative’s non-cellular RPA product and an expanded digital platform. I have studied stem cells and the potential they offer ...